- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03008577
Hypothermia and the Effect of Ambient Temperature 2 (HEAT2)
October 10, 2018 updated by: University of Texas Southwestern Medical Center
The Impact of Ambient Cesarean Room Temperature on Neonatal Morbidity
Neonatal hypothermia is associated with increased risk of mortality as well as multiple morbidities.
The prior HEAT study conducted at our institution showed a difference in neonatal hypothermia with a change in ambient operating room temperature.
The investigator's objective is to determine if an increase in ambient operative room temperature decreases the rate of neonatal morbidity.
Operating room temperature will be randomized to the current institutional standard of 20°C (67°F) or a temperature of 24°C (75°F), on a weekly basis for a period of 1.2 years.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an open, prospective, randomized, single center trial that will address the primary research question: Does an increase in ambient operating room temperature result in a lower rate of composite neonatal morbidities?
During the 1.2 year study period, the operating room temperatures on labor and delivery will be adjusted to either the current standard of care with ambient operating room temperature of 20°C (67°F), or the maximum temperature allowable per hospital policy in the current operating rooms, which is 24°C (75°F), as determined by cluster randomization.
Composite neonatal morbidities will be recorded including hypoglycemia necessitating treatment; need for respiratory support within the first 24 hours; culture-proven sepsis; and mortality.
Association of outcomes with the types of passive and active warming performed will include these morbidities stratified by gestational age as well as maternal outcomes.
In addition, an electronic survey will be administered to the operating resident physicians to assess their experience with the study conditions.
Study Type
Interventional
Enrollment (Actual)
5221
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75235
- Parkland Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- All pregnant women and their neonates undergoing cesarean delivery by the Parkland Hospital Obstetrics Service on the Labor and Delivery unit during the study period.
Exclusion Criteria:
- Exclusion criteria include cases where a cesarean delivery is planned but a precipitous vaginal delivery occurs, intrauterine fetal demise has been diagnosed prior to start of surgery, the neonate is noted to have a major congenital anomaly and resuscitative efforts are not performed ("comfort care only" provided), or a neonatal temperature is not available.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Ambient operating room temperature of 67°F
These patients will have an operating room temperature of 67°F for cesarean delivery, the standard of care at our institution.
|
|
Active Comparator: Ambient operating room temperature of 75°F
Intervention: Ambient operating room temperature of 75°F for cesarean delivery, which is closer to World Health Organization recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neonatal Composite Morbidities
Time Frame: Up to 24 hours following delivery
|
Need for respiratory support, Hypoglycemia necessitating treatment, Culture-proven sepsis; Mortality
|
Up to 24 hours following delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal Recovery Room Dwell Times after Cesarean
Time Frame: Up to 48h following delivery
|
Up to 48h following delivery
|
|
Maternal Hypothermia
Time Frame: Up to 24 hours after delivery
|
An oral temperature of less than 36.5C
|
Up to 24 hours after delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
December 28, 2016
First Submitted That Met QC Criteria
December 28, 2016
First Posted (Estimate)
January 2, 2017
Study Record Updates
Last Update Posted (Actual)
October 15, 2018
Last Update Submitted That Met QC Criteria
October 10, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 062016-040
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Atatürk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
-
Hallym University Kangnam Sacred Heart HospitalCompletedCesarean SectionKorea, Republic of
Clinical Trials on Change in ambient operating room temperature
-
University of Texas Southwestern Medical CenterCompleted
-
Chulalongkorn UniversityCompletedAllergic RhinitisThailand
-
West China HospitalCompletedLiver TransplantationChina
-
Pusan National University Yangsan HospitalCompletedExtubation in the OR After LDLTKorea, Republic of
-
University Hospital, LilleCompletedHypovolemia | Somatic PainFrance
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPostoperative Nausea and VomitingNetherlands
-
University of DundeeCompleted
-
Universidade Estadual de LondrinaCompleted
-
Moritz Stolla, MDUnited States Department of DefenseRecruitingHemorrhage | Bleeding | Surgical Blood Loss | Platelets; DefectUnited States